BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18407364)

  • 1. Determination of editors at the novel A-to-I editing positions.
    Nishimoto Y; Yamashita T; Hideyama T; Tsuji S; Suzuki N; Kwak S
    Neurosci Res; 2008 Jun; 61(2):201-6. PubMed ID: 18407364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research.
    Kwak S; Nishimoto Y; Yamashita T
    RNA Biol; 2008; 5(4):193-7. PubMed ID: 18971634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel etiological and therapeutic strategies for neurodiseases: RNA editing enzyme abnormality in sporadic amyotrophic lateral sclerosis.
    Hideyama T; Yamashita T; Nishimoto Y; Suzuki T; Kwak S
    J Pharmacol Sci; 2010; 113(1):9-13. PubMed ID: 20424386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
    Sawada J; Yamashita T; Aizawa H; Aburakawa Y; Hasebe N; Kwak S
    Neurosci Res; 2009 Jul; 64(3):251-8. PubMed ID: 19447293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound downregulation of the RNA editing enzyme ADAR2 in ALS spinal motor neurons.
    Hideyama T; Yamashita T; Aizawa H; Tsuji S; Kakita A; Takahashi H; Kwak S
    Neurobiol Dis; 2012 Mar; 45(3):1121-8. PubMed ID: 22226999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia.
    Peng PL; Zhong X; Tu W; Soundarapandian MM; Molner P; Zhu D; Lau L; Liu S; Liu F; Lu Y
    Neuron; 2006 Mar; 49(5):719-33. PubMed ID: 16504947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA receptor-mediated neuronal death in sporadic ALS.
    Kwak S; Hideyama T; Yamashita T; Aizawa H
    Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2.
    Higuchi M; Maas S; Single FN; Hartner J; Rozov A; Burnashev N; Feldmeyer D; Sprengel R; Seeburg PH
    Nature; 2000 Jul; 406(6791):78-81. PubMed ID: 10894545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionarily conserved human targets of adenosine to inosine RNA editing.
    Levanon EY; Hallegger M; Kinar Y; Shemesh R; Djinovic-Carugo K; Rechavi G; Jantsch MF; Eisenberg E
    Nucleic Acids Res; 2005; 33(4):1162-8. PubMed ID: 15731336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs.
    Vitali P; Basyuk E; Le Meur E; Bertrand E; Muscatelli F; Cavaillé J; Huttenhofer A
    J Cell Biol; 2005 Jun; 169(5):745-53. PubMed ID: 15939761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method to find tissue-specific novel sites of selective adenosine deamination.
    Ohlson J; Ensterö M; Sjöberg BM; Ohman M
    Nucleic Acids Res; 2005 Oct; 33(19):e167. PubMed ID: 16257978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate receptors: RNA editing and death of motor neurons.
    Kawahara Y; Ito K; Sun H; Aizawa H; Kanazawa I; Kwak S
    Nature; 2004 Feb; 427(6977):801. PubMed ID: 14985749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
    Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
    Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
    Kwak S; Kawahara Y
    J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tad1p, a yeast tRNA-specific adenosine deaminase, is related to the mammalian pre-mRNA editing enzymes ADAR1 and ADAR2.
    Gerber A; Grosjean H; Melcher T; Keller W
    EMBO J; 1998 Aug; 17(16):4780-9. PubMed ID: 9707437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of alternative splicing by RNA editing.
    Rueter SM; Dawson TR; Emeson RB
    Nature; 1999 May; 399(6731):75-80. PubMed ID: 10331393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR2-dependent A-to-I RNA editing in the extracellular linear and circular RNAs.
    Hosaka T; Yamashita T; Teramoto S; Hirose N; Tamaoka A; Kwak S
    Neurosci Res; 2019 Oct; 147():48-57. PubMed ID: 30448461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.
    Hideyama T; Yamashita T; Suzuki T; Tsuji S; Higuchi M; Seeburg PH; Takahashi R; Misawa H; Kwak S
    J Neurosci; 2010 Sep; 30(36):11917-25. PubMed ID: 20826656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low editing efficiency of GluR2 mRNA is associated with a low relative abundance of ADAR2 mRNA in white matter of normal human brain.
    Kawahara Y; Ito K; Sun H; Kanazawa I; Kwak S
    Eur J Neurosci; 2003 Jul; 18(1):23-33. PubMed ID: 12859334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.